Unlocking the power of the immune system (2018)
Led by Dr Martin Miller at the University of Cambridge, the main aim of this project is to research the immune system and its potential to transform ovarian cancer treatments.
Genetic testing in epithelial ovarian cancer study (2012)
Led by Dr Marc Tischkowitz, the team wanted to see if a more streamlined model of genetic counselling alongside testing for BRCA1 and BRCA2 mutations was cost effective, feasible and acceptable to women.
Targeting microtubules to overcome resistance to chemotherapy drugs (2012)
With very few treatment options for ovarian cancer, many women become resistant to one of the two key drugs used in chemotherapy, and sadly have no other alternatives. Professor Ahmed's team looked at how microtubules are involved in resistance to paclitaxel chemotherapy.